tradingkey.logo

Mesa Laboratories Inc

MLAB
View Detailed Chart

69.170USD

+4.020+6.17%
Close 09/18, 16:00ETQuotes delayed by 15 min
380.54MMarket Cap
LossP/E TTM

Mesa Laboratories Inc

69.170

+4.020+6.17%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.17%

5 Days

+9.64%

1 Month

+1.13%

6 Months

-45.16%

Year to Date

-47.55%

1 Year

-45.17%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-18

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
69 / 207
Overall Ranking
181 / 4721
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 3 analysts
Buy
Current Rating
88.500
Target Price
+35.84%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. It also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. It has manufacturing operations in the United States and Europe.
Undervalued
The company’s latest PE is -556.92, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.60M shares, decreasing 8.81% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 388.10K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 1.06.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. It also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. It has manufacturing operations in the United States and Europe.
Ticker SymbolMLAB
CompanyMesa Laboratories Inc
CEOMr. Gary M. Owens
Websitehttps://mesalabs.com
KeyAI